Yahoo Finance

Cone Rod Dystrophy Market Research Report 2025-2035: Gene Editing and Collaborations Drive Innovations

Dublin, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The "Cone Rod Dystrophy Market - A Global and Regional Analysis: Focus on Regional and Country Analysis - Analysis and Forecast, 2025-2035" report has been ...
Ophthalmology Times

No significant visual gains seen with PDE6A gene supplementation in early-phase trial

PDE6A-associated RP, a rare form of inherited retinal disease (IRD), is characterized by nyctalopia, visual field defects, and significant loss of visual acuity (VA). The disease primarily affects the ...
Business Wire

VARIANT Receives European Orphan Drug Designation for its Gene Therapy Product Candidate, VAR002, for the Treatment of Both Leber Congenital Amaurosis and Cone-Rod dystrophy

PARIS--(BUSINESS WIRE)--Variant, a company dedicated to developing innovative treatments for inherited eye orphan diseases, announces the decision of the European Commission to grant Orphan Drug ...
Mena FN

Cone Rod Dystrophy Market Research Report 2025-2035: Gene Editing And Collaborations Drive Innovations

(MENAFN- GlobeNewsWire - Nasdaq) Cone rod dystrophy is a rare inherited retinal disorder impacting cones and rods, leading to progressive vision loss. The market for cone rod dystrophy is poised for ...